MARKET

IXIC

IXIC

NASDAQ
IDXNASDAQ
15,996.82
-44.80
-0.28%
Closed 17:15 02/23 EST
OPEN
16,094.80
PREV CLOSE
16,041.62
HIGH
16,134.22
LOW
15,954.50
52 WEEK HIGH
16,134.22
52 WEEK LOW
10,982.80
VOLUME
1.00B
% RANGE
1.12%
1D
5D
1M
3M
1Y
5Y
Is It Time To Consider Buying Backblaze, Inc. (NASDAQ:BLZE)?
Backblaze, Inc. (NASDAQ:BLZE) is trading around its fair value. The company is expected to grow its profit by 43% over the next couple of years. Backblaze has seen a substantial price increase in the last year. The stock is currently valued at around 8.68% above its intrinsic value. Is the stock still a bargain? We look at the company's outlook and valuation to see if the opportunity still exists.
Simply Wall St · 14h ago
Smith Micro Software, Inc. (NASDAQ:SMSI) Just Reported And Analysts Have Been Cutting Their Estimates
Smith Micro Software, Inc. (NASDAQ:SMSI) shares have dropped 40% since its annual report. Revenues came in at US$41m, in line with expectations, but statutory losses per share were higher than expected. The analysts have downgraded their revenue estimates for Smith Micro Software for 2024. The company is expected to see a 26% decline in revenue compared to the last year. The stock is now down 40% from its previous value of US$0.49.
Simply Wall St · 14h ago
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Apollo Medical Holdings, Inc. (NASDAQ:AMEH) led the NASDAQCM gainers with a large price hike in the past few weeks. The company is inching closer to its yearly highs. Apollo Medical Holdings appears to be expensive compared to the Healthcare industry. The stock is trading above its peers and is expected to double in the next few years. Let's look at the company's valuation and outlook to see if there is still an opportunity to buy.
Simply Wall St · 15h ago
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Released Earnings Last Week And Analysts Lifted Their Price Target To US$47.43
Kymera Therapeutics, Inc. (NASDAQ:KYMR) came out with strong full-year numbers last week. Revenues were 13% higher than expected, but the company still lost US$2.52 per share. The company is expected to lose 36% of its revenues in the year to 2024. Analysts are also downgrading their revenue estimates for the company for next year. The consensus price target for the stock is now at US$47.43. We look at what the analysts are expecting for KymeraTherapeutics in the long term.
Simply Wall St · 15h ago
Old Point Financial (NASDAQ:OPOF) Is Paying Out A Dividend Of $0.14
Old Point Financial Corporation (NASDAQ:OPOF) will pay a dividend of $0.14 per share on the 29th of March. The company has been paying a dividend for the last 10 years. Old Point Financial's payout is expected to be around the industry average of 3.4%. It has a solid track record of growing its earnings at 9.9% per year over the past five years.
Simply Wall St · 16h ago
Orange County Bancorp, Inc. (NASDAQ:OBT) Passed Our Checks, And It's About To Pay A US$0.23 Dividend
Orange County Bancorp, Inc. (NASDAQ:OBT) is about to trade ex-dividend in the next 4 days. The company's next dividend payment will be US$0.23 per share. It has a trailing yield of 2.0% and has grown its earnings by 23% a year for the past five years. Orange county bancorp paid out just 18% of its profit last year.
Simply Wall St · 16h ago
First US Bancshares (NASDAQ:FUSB) Has Announced A Dividend Of $0.05
First US Bancshares, Inc.'s investors are due to receive a payment of $0.05 per share on 1st of April. The dividend yield on the stock will be 1.9%. The company has a long history of paying dividends and has a low payout ratio of 14%. First US Banchshares has seen its earnings rise by 30% in the last five years.
Simply Wall St · 16h ago
When Will Compass, Inc. (NYSE:COMP) Turn A Profit?
Compass, Inc. Provides real estate brokerage services in the United States. The company is on the verge of breakeven and is expected to turn a profit in 2026. An average annual growth rate of 68% is expected for the company. Simply Wall St takes a look at the company's future prospects.
Forward News · 16h ago
More